| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 2.729 | 11.086 | 58.569 | 5.547 | 99 | 0 | 11.173 | 105.687 | 900 |
| Total Income - EUR | 2.948 | 2.729 | 11.086 | 58.569 | 5.547 | 15.291 | 0 | 11.173 | 106.423 | 902 |
| Total Expenses - EUR | 4.472 | 8.277 | 9.367 | 10.393 | 5.028 | 20.249 | 322 | 500 | 100.211 | 95 |
| Gross Profit/Loss - EUR | -1.524 | -5.548 | 1.720 | 48.175 | 519 | -4.958 | -322 | 10.673 | 6.212 | 807 |
| Net Profit/Loss - EUR | -1.524 | -5.575 | 1.609 | 47.366 | 353 | -4.961 | -322 | 10.338 | 5.218 | 678 |
| Employees | 1 | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medifactor Brockerage S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.083 | 18.889 | 18.569 | 18.228 | 17.875 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 87 | 114 | 1.146 | 40.565 | 4.233 | 3.909 | 3.836 | 7.308 | 8.314 | 9.043 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 122 | 1.122 | 1.181 | 4.003 | 3.927 | 3.840 | 3.638 | 4.669 | 5.414 |
| Cash | 87 | -9 | 24 | 39.384 | 229 | -18 | -5 | 3.670 | 3.646 | 3.629 |
| Shareholders Funds | -1.479 | -7.040 | -5.312 | 42.152 | 1.761 | -3.233 | -3.484 | 6.843 | 5.267 | 5.915 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.119 | 26.042 | 8.941 | 851 | 4.862 | 7.142 | 7.319 | 465 | 3.048 | 3.128 |
| Income in Advance | 16.531 | 16.363 | 16.086 | 15.790 | 15.485 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6209 - 6209" | |||||||||
| CAEN Financial Year |
6209
|
|||||||||
Comments - Medifactor Brockerage S.r.l.